Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chevret

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Intensive Care Medicine|October 31, 2001
Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issueS Chevret
Revue Des Maladies Respiratoires|November 25, 2003
[Why and how randomise a clinical trial?]S Chevret
Statistics in Medicine|June 30, 1993
The continual reassessment method in cancer phase I clinical trials: a simulation studyS Chevret
Statistics in Medicine|January 10, 2002
Analysis of recurrent failure times data: should the baseline hazard be stratified?C Mahé, S Chevret
Statistics in Medicine|September 25, 2001
The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studiesS Zohar, S Chevret
Biometrics|April 21, 2001
Estimating regression parameters and degree of dependence for multivariate failure time dataC Mahé, S Chevret
Intensive Care Medicine|November 16, 2018
Intensive care medicine in 2050: clinical trials designsM Gasparini, S Chevret
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2024
Caution against overoptimistic findingsS Kouzan, S Chevret
Statistics in Medicine|July 17, 1999
Estimation of the treatment effect in a clinical trial when recurrent events define the endpointC Mahé, S Chevret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 1, 1991
[Cardiovascular risks induced by estrogens prescribed at low doses. 208 years of observation--137 patients]S Chevret, C Chastang
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Intensive Care Medicine|October 31, 2001
Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issueS Chevret
Revue Des Maladies Respiratoires|November 25, 2003
[Why and how randomise a clinical trial?]S Chevret
Statistics in Medicine|June 30, 1993
The continual reassessment method in cancer phase I clinical trials: a simulation studyS Chevret
Statistics in Medicine|January 10, 2002
Analysis of recurrent failure times data: should the baseline hazard be stratified?C Mahé, S Chevret
Statistics in Medicine|September 25, 2001
The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studiesS Zohar, S Chevret
Biometrics|April 21, 2001
Estimating regression parameters and degree of dependence for multivariate failure time dataC Mahé, S Chevret
Intensive Care Medicine|November 16, 2018
Intensive care medicine in 2050: clinical trials designsM Gasparini, S Chevret
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2024
Caution against overoptimistic findingsS Kouzan, S Chevret
Statistics in Medicine|July 17, 1999
Estimation of the treatment effect in a clinical trial when recurrent events define the endpointC Mahé, S Chevret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 1, 1991
[Cardiovascular risks induced by estrogens prescribed at low doses. 208 years of observation--137 patients]S Chevret, C Chastang
Pageof 23